Key facts
- Cryosa’s last known valuation is $50.0M (Jul 2025).
- It has raised $40.2M across 1 recorded rounds; the latest was Early Stage VC ($6.0M) in Jun 2025.
- Notable investors include Brightstone Venture Capital, Gershon Capital, Gravity Fund, Hoya (Japan), New Day Venture Capital — 7 tracked in total.
- Cryosa has filed 1 Form D with the SEC, most recently Aug 2025 ($6.0M sold to 20 investors).
- Status: Privately Held (backing).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Cryosa
Create free account
No card required
Funding rounds
1 roundsAbout Cryosa
Developer of a medical device designed to assist patients with sleep-disordered breathing. The company's device offers treatments that are focused on treating obstructive sleep apnea, enabling people suffering from moderate to severe sleep apnea disorder.
- Sector
- Healthcare
- HQ
- Arden Hills, MN, United States
- Founded
- 2018
- Employees
- 13
- Website
- cryosa.com/
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
Cryosa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Cryosa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Cryosa in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.